Drug · DIN 02489503 · Veterinary
CLAVAMOX
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since October 20, 2019; first marketed October 20, 2019.
- Drug Identification Number (DIN)
- 02489503
- Company (DIN owner)
- Zoetis Canada IncKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet (Chewable)
- Route
- Oral
- Class
- Veterinary
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| AMOXICILLIN (AMOXICILLIN TRIHYDRATE) | 200 MG | |
| CLAVULANIC ACID (CLAVULANATE POTASSIUM) | 50 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 19, 2019: NOC 22305Supplement to a New Drug Submission (SNDS) · New dosage form (chewable tablets)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “clavamox”. A notice may cover another product or only some lots: read it to see what it covers.
- Zoetis Canada Clavamox product recall (2020-02-21)February 21, 2020 · Veterinary drugs · Product safety · Type II
Other DINs named CLAVAMOX
- DIN 02489473 · Marketed
- DIN 02489481 · Marketed
- DIN 02489511 · Marketed
- DIN 02038315 · Cancelled Post Market
- DIN 02038323 · Cancelled Post Market
- DIN 02038331 · Cancelled Post Market
- DIN 02038358 · Cancelled Post Market